TERN — TERNS PHARMACEUTICALS INC

Ownership history in ORBIMED ADVISORS LLC  ·  20 quarters on record

This page tracks every 13F SEC filing in which ORBIMED ADVISORS LLC reported a position in TERNS PHARMACEUTICALS INC (TERN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.78% (2025 Q4)
Avg. % of fund
0.89%
First filed
2021 Q1
Last filed
2025 Q4
Quarters held
20
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 2,153,300 -5,409,671 -71.5% 1.78% $87.0M $40.40
2025 Q3 UNCHANGED 7,562,971 — 0% 1.33% $56.8M $7.51
2025 Q2 UNCHANGED 7,562,971 — 0% 0.70% $28.2M $3.73
2025 Q1 UNCHANGED 7,562,971 — 0% 0.50% $20.9M $2.76
16 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    TERN price (monthly, adj. close)

Other funds also holding TERN

As of 2025 Q4 — sorted by position size

ACORN CAPITAL ADVISORS, LLC 23.9% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 17.48% Vivo Capital, LLC 3Y 7Y 13.96% SUPERSTRING CAPITAL MANAGEMENT LP 9.6% Vestal Point Capital, LP 6.18% Ikarian Capital, LLC 3Y 5.04% Monashee Investment Management LLC 3Y 7Y 4.49% First Turn Management, LLC 4.03% Commodore Capital LP 3Y 3.97% STEMPOINT CAPITAL LP 2.97%
← Back to ORBIMED ADVISORS LLC Holdings